Biom Pharmaceutical: Health Revolution with Microbiome Tech

In the rapidly evolving field of biotechnology, Biom Pharmaceutical is emerging as a trailblazer, pioneering advancements in microbiome technology. Founded in 2016 by the visionary scientist and entrepreneur Dr. Bobban Subhadra, alongside his business-savvy wife, Vijitha, Biom Pharmaceutical has set a new standard in the biotech industry. This certified women-owned small biotech firm is on a mission to extend the human lifespan and enhance health quality by harnessing the power of the human microbiome.

A Groundbreaking Journey into Microbiome Research

Dr. Subhadra’s journey into microbiome research was sparked by the National Institutes of Health’s Human Microbiome Project. His fascination with the project’s findings on the correlation between microbial flora and human health led to the development of Biom’s proprietary LiveBIOM Microbiome Technology™. This platform technology facilitates the creation of designer gut flora tailored to human gut conditions, thus positively impacting health by maintaining a healthy balance of “good” flora.

Innovating for Health and Wellness

Under the leadership of Dr. Subhadra and Vijitha, Biom Pharmaceutical has developed an impressive portfolio of 24 microbiome-based products, including the groundbreaking VagiBIOM® Probiotic Suppository. This product, born from a casual conversation and a deep understanding of microbiome dysbiosis, represents a significant breakthrough in feminine health, offering a natural, preservative-free solution to intimate health issues.

Biom Pharmaceutical’s commitment to innovation is further demonstrated by its application of the LiveBIOM technology in developing live bacterial therapeutics. Currently, in preclinical and clinical trials, these therapeutics show promise for various neurological conditions, underscoring Biom’s role as a pioneer in microbiome-based consumer care and pharmaceutical products.

A Foundation Built on Science and Quality

What sets Biom Pharmaceutical apart is its unwavering commitment to science-backed, high-quality products. Utilizing its patented Biomsify® Probiotic Technology, the company ensures that each product, from gut health to feminine hygiene, meets the highest standards of quality and efficacy. Sourcing ingredients from reputable suppliers across the U.S., Europe, and Japan, Biom guarantees true-to-label, clinically tested products that live up to their full potency promise.

A Vision for a Healthier Future

At the heart of Biom Pharmaceutical is a deep-seated belief in the power of probiotics to transform lives. The team’s passion is fueled by customer testimonials, sharing stories of improved gut health, resolved chronic issues, and enhanced quality of life. This customer-centric approach, combined with a relentless pursuit of innovation, positions Biom as a leader in the biotech space.

Expanding Impact and Community Engagement

Biom Pharmaceutical is not just about groundbreaking products; it’s about building a community and advancing the biotech ecosystem. With four consumer brands and twenty-three products in the market, the company is actively involved in collaborative research projects and supports the local biomedical business community. By providing high-tech jobs, internships, and undergraduate scholarships, Biom is nurturing the next generation of scientists and entrepreneurs.

Dr. Maky Zanganeh on The Magic of Normal Exclusive Interview(Opens in a new browser tab)

The Future of Biom Pharmaceutical

As Biom Pharmaceutical continues to grow, its focus remains on leveraging microbiome technology to address unmet health needs. With five issued U.S. patents and a growing portfolio of innovative products, Biom is poised to make significant contributions to human health and wellness. For consumers and biotech funding groups alike, Biom’s story of innovation, IP strength, and future goals is not just compelling—it’s transformative. Recently, Tom Gardner, a veteran business leader,  joined the company as executive chairman to give strategic leadership. In joining, Gardner said, “I am enthused by the potential of BIOM and their promising pharmaceutical and consumer healthcare businesses backed by a patent-protected microbiome technology platform. BIOM is a company with a strong commitment to improving the lives of patients through the introduction of transformative therapies and innovative solutions”. In a world where health and longevity are paramount, Biom Pharmaceutical stands as a beacon of hope, driving forward with its pioneering microbiome technology.

Exit mobile version